At a glance
Possible toolACQ-55 · Licensing & IP
Authority holder: Agency or laboratory head and designated distribution officials
Licensing & IP
Mechanism tags describe the source text; they do not expand the authority.
Availability and verificationExpress statutory pathway; award-specific appropriations, available balances, delegations, implementation and approvals not independently verified.
Program process and intake
Checked 2026-10-04 · process documented. Program evidence is separate from legal authority, available funds and transaction approval.
Identify the actual royalty administrator while keeping internal receipts distinct from external financing.
DAF patent royalty administration
- Who this route serves
- Federal inventors, laboratories and royalty administrators; not outside grant applicants
- Administering office / routing lead
- DAF Technology Transfer and Transition program office and responsible laboratory
Related processOperational responsibility for royalty disbursement is documented; the statute, not the office description, controls distribution and permitted uses.
What this evidence label means Internal administration documentedThe published process was checked; no award or appointment availability is inferred.
Status reference date: 2026-10-04 · research checked 2026-10-04
DAF Technology Transfer program office · Overview; institutional contact detailsofficial program guidance · Evidence record Program eligibility
Steps and preparation
Funding, limits and authority relationship
Read the official process →
program information: Information and institutional inquiry, not an award application.
Research scope and sources checked
The first program-depth pass checked the cited program pages, notices and legal framework. Evidence is limited to the named routes and source-access notes; it does not establish every implementation of the statute.
What remains unverified
- No public DAF-wide current balance, inventor-specific entitlement or detailed disbursement form was verified.
A dated source check is not continuing monitoring. Recheck the linked official notice before preparing a submission. Browse program research →
Funding conditions
- Balance generally available in receipt year and two succeeding fiscal years; statutory inventor share and distribution rules precede reinvestment.
Read the funding and execution guide
Who contributes what
Need & planning
- Laboratory scientific lead and Office of Research and Technology Applications
Resources
- Laboratory director and sponsoring component budget owner
Approval
- Laboratory director and agency approver as statute/delegation requires
Execution
- Laboratory ORTA, counsel and authorized agreement official
Partners & review
- Industry, universities, nonprofit and government collaborators within eligibility limits
Office links are editorial matches to the original role text, not verified delegations. Composite labels and unmatched actors are preserved.
Coordination pathwayORTA/license administrator collects royalties → agency/lab fiscal officials distribute statutory shares → director funds eligible mission activities → return required balances.
Actor and execution-role sources
What this research establishes
Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedBalance generally available in receipt year and two succeeding fiscal years; statutory inventor share and distribution rules precede reinvestment. Office budget figures are separate institutional context, not an allocation to this instrument. Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent. EngagementRelated evidenceIdentify the actual royalty administrator while keeping internal receipts distinct from external financing. Program check: 2026-10-04; see each route for intake status. Confidence: High on express authority and cited conditions; execution assignment is illustrative unless statute expressly names it.
Currentness: GovInfo 2024 Code (includes FY2025 NDAA, P.L. 118-159) read in full for cited provision; targeted FY2026 NDAA P.L. 119-60 amendment/repeal sweep. No claim of complete legislative currency through 2026-10-02; remaining 2026 delta needs counsel validation.
Review scope: Original research target October 2, 2026; no record-specific last-review date supplied. Publication is not legal-currentness certification.